报价延迟最少15分钟:2025/11/21 07:30 EST
盘前时段
|
||||
|
-- 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
27.67
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.16/-0.49
|
|
企业价值
2.47B
|
| 资产负债 |
|
每股账面净值
2.99
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
125.81M
|
|
每股收益
--
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derivesmaximum revenue from United States. |
